Bharathiraja Subramaniyan
Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunity, Innate | 2 | 2025 | 212 | 1.480 |
Why?
|
| Photochemotherapy | 3 | 2025 | 40 | 1.060 |
Why?
|
| Receptors, Steroid | 1 | 2025 | 26 | 0.950 |
Why?
|
| Bronchi | 2 | 2021 | 38 | 0.920 |
Why?
|
| Antiviral Agents | 1 | 2025 | 111 | 0.900 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2020 | 52 | 0.820 |
Why?
|
| Paclitaxel | 2 | 2020 | 184 | 0.780 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 51 | 0.730 |
Why?
|
| Prodrugs | 2 | 2020 | 29 | 0.710 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 448 | 0.630 |
Why?
|
| Receptor, Notch3 | 3 | 2022 | 15 | 0.430 |
Why?
|
| Epithelial Cells | 3 | 2023 | 241 | 0.390 |
Why?
|
| Lung | 2 | 2023 | 363 | 0.330 |
Why?
|
| Cell Differentiation | 2 | 2021 | 398 | 0.310 |
Why?
|
| Humans | 9 | 2025 | 27136 | 0.280 |
Why?
|
| Animals | 5 | 2025 | 10085 | 0.270 |
Why?
|
| Erbium | 1 | 2025 | 1 | 0.250 |
Why?
|
| Ferrocyanides | 1 | 2025 | 3 | 0.250 |
Why?
|
| Durapatite | 1 | 2025 | 15 | 0.240 |
Why?
|
| Virus Replication | 1 | 2025 | 63 | 0.240 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2023 | 6 | 0.220 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 65 | 0.220 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 14 | 0.220 |
Why?
|
| Signal Transduction | 4 | 2022 | 1379 | 0.210 |
Why?
|
| Papio | 1 | 2023 | 78 | 0.210 |
Why?
|
| Biological Phenomena | 1 | 2022 | 4 | 0.200 |
Why?
|
| Lung Diseases | 1 | 2022 | 42 | 0.190 |
Why?
|
| Cells, Cultured | 2 | 2021 | 977 | 0.190 |
Why?
|
| Cell Death | 1 | 2021 | 111 | 0.180 |
Why?
|
| Goblet Cells | 1 | 2021 | 14 | 0.180 |
Why?
|
| Interferons | 1 | 2021 | 68 | 0.180 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 53 | 0.180 |
Why?
|
| Nanoparticles | 1 | 2025 | 276 | 0.180 |
Why?
|
| Smoke | 1 | 2021 | 36 | 0.180 |
Why?
|
| Repressor Proteins | 1 | 2021 | 114 | 0.180 |
Why?
|
| Cellular Senescence | 1 | 2021 | 121 | 0.180 |
Why?
|
| Rats, Inbred F344 | 1 | 2020 | 168 | 0.170 |
Why?
|
| Cigarette Smoking | 1 | 2021 | 77 | 0.160 |
Why?
|
| Cytokines | 1 | 2021 | 440 | 0.160 |
Why?
|
| Female | 4 | 2025 | 14650 | 0.150 |
Why?
|
| Tobacco Products | 1 | 2021 | 190 | 0.140 |
Why?
|
| Inflammation | 1 | 2021 | 608 | 0.140 |
Why?
|
| Models, Biological | 1 | 2019 | 448 | 0.140 |
Why?
|
| Rats | 1 | 2020 | 1554 | 0.130 |
Why?
|
| Aged | 2 | 2021 | 5228 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1405 | 0.120 |
Why?
|
| Aging | 1 | 2021 | 952 | 0.110 |
Why?
|
| Male | 2 | 2021 | 13034 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 1269 | 0.080 |
Why?
|
| Time Factors | 2 | 2021 | 1571 | 0.060 |
Why?
|
| Cell Survival | 1 | 2025 | 395 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 280 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2022 | 44 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 46 | 0.050 |
Why?
|
| Air | 1 | 2021 | 23 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2021 | 24 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 27 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 195 | 0.040 |
Why?
|
| Smokers | 1 | 2021 | 124 | 0.040 |
Why?
|
| Transcriptome | 1 | 2021 | 205 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 707 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2021 | 775 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 626 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 116 | 0.040 |
Why?
|
| Middle Aged | 1 | 2021 | 6906 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 4474 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 7499 | 0.020 |
Why?
|